| Code | CSB-RA011590MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to GB-7624, targeting interleukin-13 (IL-13), a key type 2 cytokine produced primarily by activated T helper 2 cells, basophils, and eosinophils. IL-13 plays a central role in allergic inflammation and tissue remodeling by promoting IgE class switching, mucus hypersecretion, airway hyperresponsiveness, and fibrosis. Dysregulated IL-13 signaling is implicated in various pathological conditions including asthma, atopic dermatitis, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and eosinophilic esophagitis, making it an important therapeutic target for allergic and inflammatory diseases.
GB-7624 is a reference antibody designed to neutralize IL-13 biological activity by blocking its interaction with IL-13 receptors. This biosimilar provides researchers with a valuable tool for investigating IL-13-mediated pathways, studying type 2 immune responses, exploring mechanisms of allergic inflammation, and evaluating potential therapeutic strategies for IL-13-associated disorders. The antibody supports various in vitro and in vivo research applications aimed at understanding cytokine biology and disease pathogenesis.
There are currently no reviews for this product.